Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huyang Xie

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|May 1, 2025
Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinomaKun Zhang, Huyang Xie, Fan Zhao, et al.
European Journal of Immunology|November 11, 2022
Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinomaYi Wang, Hao Ji, Bingye Zhu, et al.
BMC Urology|August 2, 2025
Predictive value of inflammatory marker PLR in prostate cancerJunhao Sun, Yu Song, Yunfei Tan, et al.
BMC Urology|April 10, 2024
Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencingJunhao Sun, Xinyu Zhang, Fan Wu, et al.
Mediators of Inflammation|March 16, 2026
Mendelian Randomization Identified SLC2A9 as a Novel cis-eQTL-Mediated Susceptibility Gene in Suppressing Renal Cancer and Its Related Metabolic MechanismsYi Wang, Yu Song, Hao Ji, et al.
Biomed Research International|May 22, 2019
MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5Qianwei Xing, Huyang Xie, Bingye Zhu, et al.
Oncology Letters|March 15, 2019
circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762Guowen Lin, Haoyue Sheng, Huyang Xie, et al.
Scientific Reports|June 14, 2026
Diagnostic efficacy of circulating tumor cell in clinically significant prostate cancerJiajun Qian, Fan Zhao, Bo Cai, et al.
Oncotarget|July 14, 2016
CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinomaZewei Wang, Huyang Xie, Lin Zhou, et al.
Oncotarget|September 24, 2017
High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinomaHaijian Zhang, Yidong Liu, Huyang Xie, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|May 1, 2025
Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinomaKun Zhang, Huyang Xie, Fan Zhao, et al.
European Journal of Immunology|November 11, 2022
Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinomaYi Wang, Hao Ji, Bingye Zhu, et al.
BMC Urology|August 2, 2025
Predictive value of inflammatory marker PLR in prostate cancerJunhao Sun, Yu Song, Yunfei Tan, et al.
BMC Urology|April 10, 2024
Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencingJunhao Sun, Xinyu Zhang, Fan Wu, et al.
Mediators of Inflammation|March 16, 2026
Mendelian Randomization Identified SLC2A9 as a Novel cis-eQTL-Mediated Susceptibility Gene in Suppressing Renal Cancer and Its Related Metabolic MechanismsYi Wang, Yu Song, Hao Ji, et al.
Biomed Research International|May 22, 2019
MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5Qianwei Xing, Huyang Xie, Bingye Zhu, et al.
Oncology Letters|March 15, 2019
circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762Guowen Lin, Haoyue Sheng, Huyang Xie, et al.
Scientific Reports|June 14, 2026
Diagnostic efficacy of circulating tumor cell in clinically significant prostate cancerJiajun Qian, Fan Zhao, Bo Cai, et al.
Oncotarget|July 14, 2016
CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinomaZewei Wang, Huyang Xie, Lin Zhou, et al.
Oncotarget|September 24, 2017
High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinomaHaijian Zhang, Yidong Liu, Huyang Xie, et al.
Pageof 3